drugset / Trial / NCT01165021

A Study of Pemetrexed/Cisplatin as Pre-operative Treatment of Early Stage Nonsquamous Non-Small Cell Lung Cancer

NCT01165021

Phase 2 Completed 19 enrolled Eli Lilly and Company
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this trial is to assess how well the combination of pemetrexed with cisplatin can reduce tumor size.

Timeline

Start
2010-11
Primary completion
2013-07
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Pemetrexed Small molecule 500 mg/m2 Intravenous
Background Dexamethasone Small molecule Oral
Background Vitamin B12 Other / unclassified Intramuscular
Background folic acid Other / unclassified Oral